Advertisement

Topics

Four intriguing biopharma developments this week

07:06 EDT 19 Aug 2017 | MedCity News

Here’s a look at some of the most intriguing biopharma news developments this week from an investment in a new approach for early diagnosis of Alzheimer’s disease to reports highlighting flaws in the FDA’s accelerated drug and device approval programs. 

Original Article: Four intriguing biopharma developments this week

NEXT ARTICLE

More From BioPortfolio on "Four intriguing biopharma developments this week"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...